SMAD3 and colorectal carcinoma: The findings from the human TCGA dataset correlates with the genetic and microbiome alterations observed in the OTM mouse model, where there was a significant co-occurrence of alterations in SPTBN1 and SMAD3 or SMAD3 and SMAD4, which were strongly associated with poor overall survival in CRC patients.